Cellectis SA (CLLS)

3.44 +0.03 (+0.88%) USD  |  NASDAQ  |  Apr 06, 16:00
3.44 0.00 (0.00%) After-Hours: 20:00
More

Cellectis SG&A Expense (TTM) : 19.83M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
DBV Technologies SA 36.08M
EDAP TMS SA 45.01M
Sanofi 10.80B
Akari Therapeutics Plc 9.294M
Biodexa Pharmaceuticals Plc 6.375M